Human Ig knockin mice to study the development and regulation of HIV‐1 broadly neutralizing antibodies
- 30 January 2017
- journal article
- review article
- Published by Wiley in Immunological Reviews
- Vol. 275 (1) , 89-107
Abstract
Summary: A major challenge for HIV‐1 vaccine research is developing a successful immunization approach for inducing broadly neutralizing antibodies (bnAbs). A key shortcoming in meeting this challenge has been the lack of animal models capable of identifying impediments limiting bnAb induction and ranking vaccine strategies for their ability to promote bnAb development. Since 2010, immunoglobulin knockin (KI) technology, involving inserting functional rearranged human variable exons into the mouse IgH and IgL loci has been used to express bnAbs in mice. This approach has allowed immune tolerance mechanisms limiting bnAb production to be elucidated and strategies to overcome such limitations to be evaluated. From these studies, along with the wealth of knowledge afforded by analyses of recombinant Ig‐based bnAb structures, it became apparent that key functional features of bnAbs often are problematic for their elicitation in mice by classic vaccine paradigms, necessitating more iterative testing of new vaccine concepts. In this regard, bnAb KI models expressing deduced precursor V(D)J rearrangements of mature bnAbs or unrearranged germline V, D, J segments (that can be assembled into variable region exons that encode bnAb precursors), have been engineered to evaluate novel immunogens/regimens for effectiveness in driving bnAb responses. One promising approach emerging from such studies is the ability of sequentially administered, modified immunogens (designed to bind progressively more mature bnAb precursors) to initiate affinity maturation. Here, we review insights gained from bnAb KI studies regarding the regulation and induction of bnAbs, and discuss new Ig KI methodologies to manipulate the production and/or expression of bnAbs in vivo, to further facilitate vaccine‐guided bnAb induction studies.Keywords
Funding Information
- National Institutes of Health (R01AI087202, R01AI118571)
- National Institutes of Health (R01AI077595)
This publication has 146 references indexed in Scilit:
- B-cell–lineage immunogen design in vaccine development with HIV-1 as a case studyNature Biotechnology, 2012
- Antibody-based protection against HIV infection by vectored immunoprophylaxisNature, 2011
- Broad neutralization coverage of HIV by multiple highly potent antibodiesNature, 2011
- Role of immune mechanisms in induction of HIV-1 broadly neutralizing antibodiesCurrent Opinion in Immunology, 2011
- Induction of Immunity to Human Immunodeficiency Virus Type-1 by VaccinationImmunity, 2010
- Autoreactivity in an HIV-1 broadly reactive neutralizing antibody variable region heavy chain induces immunologic toleranceProceedings of the National Academy of Sciences, 2009
- Role of HIV membrane in neutralization by two broadly neutralizing antibodiesProceedings of the National Academy of Sciences, 2009
- Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: Implications for evasion of immune responses and design of vaccine immunogensBiochemical and Biophysical Research Communications, 2009
- Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursorsProceedings of the National Academy of Sciences, 2008
- Autoreactivity in Human IgG+ Memory B CellsImmunity, 2007